Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

The Effect of vırtual realıty on paın and Sleep qualıty ın Women

3 de junho de 2026 atualizado por: Remzi KARASUNGUR, Hasan Kalyoncu University

The Effect of vıdeo Watched wıth musıc Through vırtual realıty Glasses and musıc lıstenıng Alone on paın and Sleep qualıty ın Women wıth Dysmenorrhea

The aim of this study is to determine whether a video viewed through virtual reality goggles accompanied by music has an effect on pain and sleep quality in women with dysmenorrhea. The main questions it seeks to answer are as follows:

  • Does watching a video through virtual reality goggles accompanied by music reduce pain in women with dysmenorrhea?
  • Does watching a video through virtual reality goggles accompanied by music improve sleep quality in women with dysmenorrhea? The study will compare a group that uses music from the virtual reality video with another group to determine whether the virtual reality application has an effect on pain and sleep quality.

Participants will do the following:

For 3 days, use the virtual reality or music application every evening before going to bed after completing the VAS. The next day, after waking up, complete the VAS and the sleep quality scale and record the results.

Visão geral do estudo

Status

Concluído

Condições

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Real)

77

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Baykan
      • Siirt, Baykan, Turquia (Türkiye), 56460
        • Baykan State Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Women who volunteered to participate in the study,
  • Who are at least literate,
  • Aged 15-49 and not yet in menopause,
  • Who are not pregnant,
  • Who have been diagnosed with dysmenorrhea by a physician and have a pain intensity of at least 4 on the Visual Analogue Scale

Exclusion Criteria:

  • Women with dysmenorrhea pain intensity below 4 on the Visual Analog Scale,
  • Women with vision or hearing impairments,
  • Women who are unwilling to participate in the study,
  • Women using analgesic medications for menstrual pain,
  • Pregnant women

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Quadruplicar

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: experiment
Group shown a video using a virtual reality headset: For this experiment, a video featuring nature scenes and waterfalls was downloaded to a phone, loaded into a virtual reality headset, and provided to the participant ready for use.

Group shown a video using a virtual reality headset: A video containing images of nature and waterfalls is downloaded to a phone and provided to the participant ready to use inside a virtual reality headset; the procedure is carried out as described below.

For three consecutive days, each day:

  • After menstruation begins, apply the VAS pain scale before going to bed in the evening
  • In the evening, in a dark and quiet environment, watch the 30-minute virtual reality video as instructed by the researcher until falling asleep
  • The following morning, apply the VAS pain scale and RCUÖ and inform the researcher.

After the study was completed, the equipment returned to the researcher was calibrated and cleaned as necessary by the researcher and prepared for use with another patient.

Outros nomes:
  • Realidade virtual
Comparador de Placebo: control
Unlike the intervention group, the women in the control group were given MP3 players by the researcher, instructed on how to use them, and had the music used in the virtual reality video loaded onto the devices for them to listen to.

Unlike the intervention group, the women in the control group were given an MP3 player by the researcher, instructed on how to use it, and had the music used in the virtual reality video loaded onto it for them to listen to.

For three consecutive days, each day:

  • Apply the VAS pain scale in the evening before going to bed after menstruation has occurred
  • Listen to the 30-minute music in a dark and quiet environment in the evening, as instructed by the researcher
  • Apply the VAS pain scale and RCUÖ the following morning and inform the researcher.

After the study was completed, the equipment returned to the researcher was calibrated and cleaned as necessary by the researcher and prepared for use with another patient.

Outros nomes:
  • música

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Distribution of women according to the characteristics of their menstrual cycles
Prazo: 4 weeks
This table includes the latest menstrual pain scale, the occurrence of pain during the menstrual cycle, the type of dysmenorrhea, the timing of dysmenorrhea, information about menstruation, who provided information about menstruation, the use of pain relievers during the menstrual period, non-pharmacological interventions used to alleviate menstrual pain, non-pharmacological interventions used to alleviate menstrual pain, the presence of dysmenorrhea in the family, and gynecological diagnosis data. Patients with a pain scale (VAS) score of 4 or higher were evaluated, and the analysis proceeded to secondary outcomes.
4 weeks

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Comparison of Participants' Sociodemographic Characteristics by Group
Prazo: 2 weeks
This table presents sociodemographic data such as women's marital status, age, and chronic conditions.
2 weeks
A Comparison of Certain Characteristics of Participants' Menstrual Cycles Across Groups
Prazo: 4 weeks
This table presents data such as the age at first menstruation, menstrual cycle length, and duration of menstrual bleeding
4 weeks
Comparison of Dysmenorrhea Characteristics Among Participants by Group
Prazo: 4 weeks
This table examines data such as the onset of dysmenorrhea, the presence of dysmenorrhea in the family, the family history of dysmenorrhea, the severity of pain during menstruation, and the use of pain relievers during menstruation.
4 weeks
Comparison of Participants' Sleep-Related Characteristics by Group
Prazo: 4 weeks
This table provides information on a woman's sleep patterns during her menstrual cycle
4 weeks
Comparisons of Participants' Visual Analog Scale (VAS) Scores Between and Within Groups
Prazo: 6 weeks

A visual analog scale is a pain assessment tool where individuals mark their pain level on a horizontal bar ranging from 0 to 10. The starting point of the scale indicates the absence of pain, while the end point indicates that the pain is unbearable.

This table shows the woman's pain scale assessment.

6 weeks
Comparisons of Participants' Richard Campbell Sleep Scale (RCSQ) Scores Across and Within Groups
Prazo: 6 weeks
The Richard Campbell Sleep Scale assesses the depth of sleep, the time it takes to fall asleep, the frequency of waking, the duration of wakefulness upon waking, the quality of sleep, and the noise level in the environment. Each item on the scale is scored on a scale of 0 to 100. A score of "0-25" indicates "very poor sleep," while a score of "76-100" indicates "very good sleep." When calculating the total scale score, the scores from the 5 items are added together; the noise level in the environment is not included in the total score calculation.
6 weeks

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Diretor de estudo: Remzi KARASUNGUR, not affiliated

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

5 de janeiro de 2023

Conclusão Primária (Real)

29 de março de 2023

Conclusão do estudo (Real)

24 de setembro de 2023

Datas de inscrição no estudo

Enviado pela primeira vez

7 de abril de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

3 de junho de 2026

Primeira postagem (Real)

8 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

8 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

3 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Descrição do plano IPD

When our study is published as an article, the data on the individuals will be presented to researchers in tabular

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever